Israel Englander Millennium Management
Israel “Izzy” Englander is the founder of Millennium Management, one of the world’s largest multi-strategy hedge fund platforms. Millennium allocates capital across hundreds of independent teams rather than a single house view, with rigorous risk controls at the platform level. Englander’s model has been highly influential in the rise of pod-shop multi-manager structures across the industry.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
CELG
Celgene Corp
CELG
|
+$379M |
| 2 |
Starbucks
SBUX
|
+$371M |
| 3 |
APC
Anadarko Petroleum
APC
|
+$287M |
| 4 |
Bristol-Myers Squibb
BMY
|
+$263M |
| 5 |
Tesla
TSLA
|
+$253M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Fortive
FTV
|
+$1.27B |
| 2 |
ANDV
Andeavor
ANDV
|
+$1.11B |
| 3 |
AET
Aetna Inc
AET
|
+$535M |
| 4 |
Microsoft
MSFT
|
+$350M |
| 5 |
Amazon
AMZN
|
+$290M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 13.69% |
| 2 | Technology | 13.64% |
| 3 | Financials | 12.49% |
| 4 | Consumer Discretionary | 10.83% |
| 5 | Industrials | 9.5% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1301
LXP Industrial Trust
LXP
$3.6B
| $7.48M | 0.01% |
182,120
+132,051
| +264% | +$5.44M |
|
1302
iShares Russell 1000 Value ETF
IWD
$84.2B
| $7.47M | 0.01% |
67,300
-40,206
| -37% | -$4.82M |
|
1303
SLB Ltd
SLB
$79.1B
| $7.46M | 0.01% |
206,667
-34,922
| -14% | -$1.72M |
|
1304
CALL
RTX Corp
RTX
$283B
| $7.45M | 0.01% |
111,230
-47,670
| -30% | -$3.74M |
|
1305
CALL
Dentsply Sirona
XRAY
$2.19B
| $7.44M | 0.01% |
+200,000
| New | +$7.28M |
|
1306
LCI Industries
LCII
$2.55B
| $7.43M | 0.01% |
111,223
-44,830
| -29% | -$3.27M |
|
|
CDK
1307
DELISTED
CDK Global, Inc.
CDK
| $7.42M | 0.01% |
154,916
-345,514
| -69% | -$18.2M |
|
|
MDSO
1308
CALL
DELISTED
Medidata Solutions, Inc.
MDSO
| $7.42M | 0.01% |
110,000
-108,800
| -50% | -$7.68M |
|
|
CSGS
1309
DELISTED
CSG Systems International
CSGS
| $7.41M | 0.01% |
233,359
-14,779
| -6% | -$519K |
|
|
CSII
1310
DELISTED
Cardiovascular Systems, Inc.
CSII
| $7.39M | 0.01% |
259,299
-182,029
| -41% | -$5.78M |
|
1311
Crane NXT
CXT
$2.89B
| $7.37M | 0.01% |
+293,848
| New | +$8.74M |
|
1312
PUT
iShares MSCI South Korea ETF
EWY
$28B
| $7.36M | 0.01% |
125,000
| – | – |
|
1313
Thor Industries
THO
$4.14B
| $7.34M | 0.01% |
141,253
+18,543
| +15% | +$1.26M |
|
1314
CALL
Masco
MAS
$14.4B
| $7.31M | 0.01% |
250,000
| – | – |
|
|
ZGNX
1315
CALL
DELISTED
Zogenix, Inc.
ZGNX
| $7.29M | 0.01% |
+200,000
| New | +$8.19M |
|
|
CTRL
1316
DELISTED
Control4 Corporation
CTRL
| $7.29M | 0.01% |
414,149
+399,948
| +2,816% | +$9.47M |
|
1317
Steven Madden
SHOO
$3.33B
| $7.29M | 0.01% |
240,861
+121,173
| +101% | +$3.73M |
|
1318
PUT
Aon
AON
$75.3B
| $7.27M | 0.01% |
+50,000
| New | +$7.77M |
|
|
GHL
1319
DELISTED
Greenhill & Co., Inc.
GHL
| $7.26M | 0.01% |
297,687
+125,872
| +73% | +$3.08M |
|
|
ACBI
1320
DELISTED
Atlantic Capital Bancshares, Inc. Common Stock
ACBI
| $7.25M | 0.01% |
443,034
-37,321
| -8% | -$614K |
|
1321
Roper Technologies
ROP
$40.9B
| $7.24M | 0.01% |
27,158
+9,445
| +53% | +$2.67M |
|
1322
Trupanion
TRUP
$1.4B
| $7.23M | 0.01% |
284,032
+258,372
| +1,007% | +$6.95M |
|
|
PLAN
1323
DELISTED
Anaplan, Inc.
PLAN
| $7.22M | 0.01% |
+272,106
| New | +$6.73M |
|
|
SRDX
1324
DELISTED
Surmodics
SRDX
| $7.2M | 0.01% |
152,311
+46,165
| +43% | +$2.77M |
|
1325
Abeona Therapeutics
ABEO
$355M
| $7.18M | 0.01% |
40,219
+13,150
| +49% | +$2.87M |
|
Similar funds
Israel Englander's Q4 2018 Portfolio in Review
As of Q4 2018, Israel Englander held 4,541 positions worth $64.1B, down 21% from $81.6B the previous quarter. Its ten largest holdings account for 6.7% of the portfolio.
Israel Englander withdrew a net $4.25B in Q4 2018, closing 844 positions and reducing 1,571 holdings. Its most notable exit was Andeavor, an estimated $1.11B position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 14% of assets, up from 12% a quarter earlier, followed by Technology and Financials.
Against the trend, Israel Englander opened a new position in Athenahealth, Inc. worth $135M.
- Israel Englander's largest Q4 2018 buy was Athenahealth, Inc.: 1,022,505 shares worth $135M.
- Israel Englander added most to Celgene Corp in Q4 2018, an estimated $379M increase.
- Israel Englander's biggest Q4 2018 reduction was Fortive, cutting an estimated $1.27B.
- Israel Englander fully exited Andeavor in Q4 2018, selling an estimated $1.11B.
- Israel Englander's ten largest holdings make up 6.7% of its $64.1B portfolio in Q4 2018.
- Israel Englander opened 702 new positions and closed 844 in Q4 2018.
- Israel Englander's portfolio value fell 21% quarter-over-quarter to $64.1B.
Based on Millennium Management's 13F filing for Q4 2018, filed 14 Feb 2019.